Clinical trial
A Study Comparing the Effectiveness and Safety of Varying Dose Strengths (100…
NCT00325858 · Bausch Health Americas, Inc., Industry · Completed
Key facts
| NCT number | NCT00325858 |
|---|---|
| Title | A Study Comparing the Effectiveness and Safety of Varying Dose Strengths (100, 200, 300 and 400 mg) of Extended-release Tramadol HCl With Placebo for the Treatment of Osteoarthritis(OA) of the Knee and/or Hip |
| Official title | Double-Blind, Randomized,Dose-Ranging, Parallel-Group Comparison Of The Efficacy And Safety Of Extended-Release Tramadol Hydrochloride(Tramadol HCl ER)100 Mg, 200 Mg, 300 Mg, And 400 Mg With Placebo In The Treatment Of Osteoarthritis Of Knee And/Or Hip |
| Lead sponsor | Bausch Health Americas, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Pain |
| Intervention type | Drug |
| Interventions | Tramadol HCl ER |
| Enrollment | 1,000 |
| Start date | Jan 1, 2002 |
| Completion | Dec 1, 2003 |
| First posted | May 15, 2006 |
| Last update posted | Aug 27, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: